Sakin Abdullah, Sahin Suleyman, Aldemir Mehmet Naci, Iliklerden Umit Haluk, Kotan Mehmet Cetin
1Department of Medical Oncology, Yuzuncu Yil University Medical School, 65080, Van, Turkey.
J BUON. 2021 Jul-Aug;26(4):1509-1516.
We aimed to examine the effect of esophagectomy after chemoradiotherapy (CRT) or non-surgical follow-up after CRT in patients with locally advanced esophageal squamous cell carcinoma (ESCC).
A total of 653 patients under follow-up for locally advanced ESCC between 2010-2019 were reviewed for enrollment. Patients with no distant metastasis at the time of diagnosis who underwent esophagectomy or were taken under observation following CRT were included in the study. Overall, 127 eligible patients were included, 55 of whom were male (43.3%) and 72 female (56.7%).
After CRT, 59 patients (53.5%) had undergone surgery and 68 (46.5%) were taken under observation. Median disease-free survival (mDFS) was not reached in the group that underwent surgery and was 13 months in the observation group (p<0.001). Median overall survival (mOS) was significantly longer in the operated group (p=0.006). There was no statistically significant difference in DFS and OS between patients who underwent surgery and those included in the observation group after achieving clinical and pathological complete response following CRT (p=0.119, p=0.699, respectively). The multivariate analysis identified surgery and increased CRT response as the factors that affect DFS (p=0.042, p<0.001, respectively).
In this study, surgery provided no additional benefit on survival in locally advanced ESCC patients with complete response while prolonged survival was observed in those without complete response. Key words: esophageal cancer, chemoradiotherapy, squamous cell carcinoma, observation .
我们旨在研究局部晚期食管鳞状细胞癌(ESCC)患者在放化疗(CRT)后接受食管切除术或CRT后进行非手术随访的效果。
回顾性分析2010年至2019年间接受随访的653例局部晚期ESCC患者,以确定入组情况。纳入诊断时无远处转移且接受了食管切除术或CRT后接受观察的患者。总共纳入了127例符合条件的患者,其中55例为男性(43.3%),72例为女性(56.7%)。
CRT后,59例患者(53.5%)接受了手术,68例(46.5%)接受观察。手术组未达到中位无病生存期(mDFS),观察组为13个月(p<0.001)。手术组的中位总生存期(mOS)明显更长(p=0.006)。在CRT后达到临床和病理完全缓解的患者中,手术患者与观察组患者的DFS和OS无统计学显著差异(分别为p=0.119和p=0.699)。多因素分析确定手术和CRT反应增加是影响DFS的因素(分别为p=0.042和p<0.001)。
在本研究中,手术对局部晚期ESCC完全缓解患者的生存没有额外益处,而未完全缓解的患者生存期延长。关键词:食管癌;放化疗;鳞状细胞癌;观察